Pharmaceutical

TileDB Powers Multiomics Research: Now Trusted by Half of Top Global Pharma Giants

Multimodal Data Management Company Strengthens Leadership with New Board Members and Executive Appointments CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- TileDB,…

1 year ago

Petauri™ Acquires Formulary Insights™ in Market Access Expansion

Rapidly growing pharmaceutical services platform bolsters pricing and market access offering, merging business with Petauri Advisors NASHVILLE, Tenn., Nov. 13,…

1 year ago

Subtle Medical Unveils Subtle-ELITE and New Strategic Partnerships at RSNA 2024

Subtle's Latest Solutions and Partnerships Set New Benchmarks for AI-powered Acceleration and Image Quality MENLO PARK, Calif., Nov. 13, 2024…

1 year ago

C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) Initiative

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov.…

1 year ago

Ethics Board Approval Granted for Lexaria’s 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp.…

1 year ago

Jaguar Health Reports Third Quarter 2024 Financial Results

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately…

1 year ago

CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited…

1 year ago

PreveCeutical’s Subsidiary, BioGene Therapeutics, Appoints President

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

1 year ago

myTomorrows Appoints Vanessa Lemarié as Chief Operating Officer

Previously COO at leading health technology company Ada Health, Lemarié is an award-winning strategist whose expertise will further myTomorrows' mission…

1 year ago

Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

1 year ago